Akari Therapeutics Reports Full-Year 2023 Financial Results and Recent Highlights
Go back to Akari Therapeutics Reports Full-Year 2023 Financial Results and Recent Highlights| (NASDAQ: AKTX) | Delayed: 10.15 -0.22 (2.12%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $10.37 | 52 Week High | $19.75 | |||
| Open | $10.09 | 52 Week Low | $7.63 | |||
| Day High | $10.40 | P/E | N/A | |||
| Day Low | $9.60 | EPS | $0.00 | |||
| Volume | 46,499 | |||||
| (NASDAQ: AKTX) | Delayed: 10.15 -0.22 (2.12%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $10.37 | 52 Week High | $19.75 | |||
| Open | $10.09 | 52 Week Low | $7.63 | |||
| Day High | $10.40 | P/E | N/A | |||
| Day Low | $9.60 | EPS | $0.00 | |||
| Volume | 46,499 | |||||

